Interchangeable Biosimilars: Plan and Patient Savings
Adoption of biosimilars has been slow. The release of an FDA-approved interchangeable biosimilar may provide an added boost in savings.
Call 800.281.7050 | Fax 855.296.3933
Tips and trends to unlock pharmacy solutions
Search
PCM Team
- Jul 21
- 2 min
Lowering Diabetes Medication Costs with Alternative Strategies
Identifying and covering therapeutic alternatives to high-cost prescription drugs is key to a diabetic-friendly pharmacy program
PCM Team
- Jun 28
- 2 min
Medical Pharmacy Affects Plan Spend
Pharmacy costs get all the press for rising prices; however, brokers and plan sponsors need to consider medical pharmacy if they want a...
PCM Team
- May 24
- 2 min
RFP Questions You Should be Asking
When evaluating a PBM contract at renewal or mid-term market check, brokers and plan sponsors should be asking questions. Questions that...
PCM Team
- Mar 24
- 2 min
Validating Pharmacy Savings Programs
Americans spent $328 billion on prescription drugs in 2020, eight percent of total healthcare spend. The rising cost of medications is...
PCM Team
- Feb 24
- 2 min
Navigating Gene Therapies
Research on gene-therapies began in 1960 with the hypothesis that introducing DNA sequences into patients' cells could cure genetic...
PCM Team
- Jan 18
- 2 min
A Primer on J Codes
High-cost prescription drugs have been wreaking havoc on pharmacy plan budgets for over a decade. However, did you know that drugs costs...
PCM Team
- Dec 16, 2021
- 3 min
Trends to Follow in 2022
This year saw a post-pandemic return to preventive care, the introduction of several biosimilars, and legislation governing healthcare...
PCM Team
- Oct 25, 2021
- 3 min
Data and Vendor Fragmentation in Health Benefits
By identifying data and vendor silos that affect participant engagement and spend, payors and brokers can begin to build better benefits.
PCM Team
- Sep 10, 2021
- 3 min
Artificial Intelligence in Pharmacy: Improving Patient Outcomes
With its unique set of challenges, the pharmacy industry is already benefiting from AI-powered technology;
PCM Team
- Aug 18, 2021
- 2 min
Covering Specialty Drugs: Medical vs. Pharmacy Channel
For self-insured plan sponsors, specialty drugs represent 33-50% of total pharmacy spend but only account for 1% of total prescription...
PCM Team
- Jun 14, 2021
- 2 min
Drug Rebates Affect Formulary Management
It is not surprising that there is little transparency around the factors influencing formulary development—chief among those: rebates.
PCM Team
- May 12, 2021
- 3 min
A Primer on Biosimilars
The proven efficacy, safety, and cost savings of biosimilars make them a valuable weapon in the fight for more access to lower-cost
PCM Team
- Apr 15, 2021
- 3 min
Improving Medication Adherence
When paired with proactive participant engagement, data analytics can help plan sponsors improve medication adherence.
PCM Team
- Mar 17, 2021
- 3 min
Three Plan Metrics Every Employer Should Be Monitoring
60% of employers report that the cost of their current pharmacy plan is unsustainable. Without requesting bids from vendors or...
PCM Team
- Feb 17, 2021
- 2 min
Achieve Lowest Net Cost with Clinically Driven Formulary
A clinically-driven, value-based pharmacy model moves the plan toward the lowest net cost.
Dr. David Merritt PharmD, RPh
- Dec 15, 2020
- 3 min
Pharmacy: Looking forward to 2021
This year has been, in a word, unique. Fortunately, time marches on, and a new year is around the corner. This article looks forward to...
PCM Team
- Nov 17, 2020
- 3 min
Transparency Brings Balance to Drug Rebates
There are six significant stakeholders in the complex drug distribution system: pharmaceutical manufacturer, plan sponsor, pharmacy, PBM,...
Dr. David Merritt PharmD, RPh
- Oct 9, 2020
- 3 min
Specialty Drugs: What are they and what (or who) controls costs?
The cost of prescription medications is rising, but one sub-set of drugs may be disproportionately eating away at financial resources....
PCM Team
- Aug 5, 2020
- 3 min
Pharmacy Analytics: How to Lead with Data
In the pharmacy space, industry leaders are embracing data analytics to distance themselves from the competition and provide top-level benef